HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s. - Test2 - elhamkhani - TriplyDB

HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.

HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.

http://www.wikidata.org/entity/Q37416242

about

Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical Appraisal Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature Embryonic stem cell factors and pancreatic cancer CypA, a gene downstream of HIF-1α, promotes the development of PDAC Natural product (-)-gossypol inhibits colon cancer cell growth by targeting RNA-binding protein Musashi-1.Cytoplasmic EpCAM over-expression is associated with favorable clinical outcomes in pancreatic cancer patients with Hepatitis B virus negative infection.EMMPRIN-Targeted Magnetic Nanoparticles for In Vivo Visualization and Regression of Acute Myocardial Infarction.Hispidulin induces mitochondrial apoptosis in acute myeloid leukemia cells by targeting extracellular matrix metalloproteinase inducer.A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells.Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling.Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling.Antibody against CD44s inhibits pancreatic tumor initiation and postradiation recurrence in mice.Cancer stem cell markers in patterning differentiation and in prognosis of oral squamous cell carcinoma.TIP30 regulates lipid metabolism in hepatocellular carcinoma by regulating SREBP1 through the Akt/mTOR signaling pathway.HAb18G/CD147 is involved in TGF-β-induced epithelial-mesenchymal transition and hepatocellular carcinoma invasion.Surgery combined with local 5-aminolevulinic acid-photodynamic therapy on skin cancer and its effect on the expression of cyclophilin A, cyclophilin B and CD147.EMMPRIN Inhibits bFGF-Induced IL-6 Secretion in an Osteoblastic Cell Line, MC3T3-E1.Expression of proteins associated with epithelial-mesenchymal transition in esophageal squamous cell carcinoma.CD147 overexpression promotes tumorigenicity in Chinese hamster ovary cells.Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins

P2860

Q26744536-E0C1860B-EA90-4C3D-B7AD-00DE9691F650 Q26771312-60112B04-0505-45EC-921C-2BBDF5A764C8 Q33898664-442FF449-1D0E-40CB-AFA8-205F2B8A079F Q34486547-D1C06028-CA7A-4C4E-AA21-BFCA4D3A548A Q35113612-9C2F9CD0-6054-4F3C-B3C2-F87495292F9D Q35129112-985A5870-16E4-4518-A791-B6BF3DCEE01A Q35620470-39B1919E-CB72-4164-83C2-A0529283B40B Q36511460-32B0849C-E2D9-4FA7-A166-AEB6C27D5877 Q36644344-BE985465-0D26-46DC-9E8D-19FA7380476A Q36841347-60828D84-64FF-48B2-B25E-C445096445BF Q36962630-FDC8DE5C-D372-48D5-8539-FEB04FADE523 Q36998357-991ACA78-EBA7-42E6-91C7-68C336E74CE8 Q37641751-518C116A-1DE6-472F-8CCE-A8535302CBAB Q37695430-5B61357D-DDB0-49D3-A02B-A933A73AD779 Q38699708-2C4D0126-8E13-4029-9F5C-4740767955FF Q38730344-0B97FAC7-B936-49FC-A70C-D5C8A8EB04E6 Q38973523-9E4E6DB6-9621-4580-95A5-13E8742B3D5F Q41143821-3F9F52D8-0A7D-4191-A28A-B8F13C1A15CD Q47130264-20585DA3-F949-4C51-A38B-1B8F6912FE83 Q49549728-A78E0C4F-EDDD-418D-823E-3A3D50327DD0 Q50206336-E147E124-E7EA-4EBF-ADD0-A00BC3E2F8EA Q58791568-60E8E97D-5FA9-4684-B06F-2308954442FF

P2860

HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.

http://www.wikidata.org/entity/Q37416242

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.

@en

HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.

@nl

type

label

HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.

@en

HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.

@nl

prefLabel

HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.

@en

HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.

@nl

P1433

Q37416242-01288B97-9E17-4892-8407-D8A2CBD62E6C

P1476

Q37416242-359B29BF-1208-49A6-9762-254073B4AFC3

P2093

Q37416242-0200FEE2-5F80-4DF5-A9FE-70A77916A276

Q37416242-2281A04F-67C2-46B1-B5D8-11B0C53D1711

Q37416242-231AD8E5-A65C-4009-A04B-FB2798C61307

Q37416242-37AF46F3-08B8-4204-A36F-26BFD445AC32

Q37416242-460A91B2-8413-4054-BCEA-85CF303EBF5E

Q37416242-56E0ECEB-B19E-42C6-9A0A-CEFF9C971A5B

Q37416242-62D7F6C9-B347-469B-BFD6-3E214A6F627D

Q37416242-7B77E5E3-E2C7-4F3D-B4C7-30738F294E20

Q37416242-9735C8B0-8341-4C60-B699-E383447BC0C4

Q37416242-B3DA2F64-E69E-433B-9332-7D5A71C7AA0B

P2860

Q37416242-004BBF65-3A90-435D-9D8A-26DFE9E12EC3

Q37416242-04B02663-0E8C-4ED1-BCDA-558BE59CA751

Q37416242-058FCD85-36B3-4D6C-82C0-D878F3314F47

Q37416242-092BC97C-D960-4E4F-86D0-17D2DCBCAC01

Q37416242-0DE4EEA9-7F50-4A63-808A-BC58D49D8B9D

Q37416242-0EB79522-FF1A-4970-BD58-55423B81796D

Q37416242-110408AF-B732-444E-8A95-E2DE82683849

Q37416242-11F5E017-FFB1-45BC-9854-22BCDEB182DA

Q37416242-1B47061D-5803-4B3F-841E-DFCA05AE48CD

Q37416242-267DB605-21A7-42F5-A9DA-B9DE225B9417

P304

Q37416242-8F6A8AE3-D0F1-4CEC-952F-F7814B8D4460

P31

Q37416242-E6C4EB15-57B3-454F-9771-01F9AD892973

P356

Q37416242-35F8D54F-0326-4F5A-8CD8-5D5BC25E54AB

P407

Q37416242-AA8CF14F-8F16-4FA8-BA61-0C6E482711E1

P433

Q37416242-09BCD4D3-7374-4201-ACEC-66B8390A3FB3

P478

Q37416242-F521FB6B-44A6-4C78-82A2-5A20691AF667

P50

Q37416242-C61EB7AA-58DA-4B87-88A1-C5B1DDC2A3A9

P577

Q37416242-DBBB608A-325C-4361-BDBA-05D6A5C53A6F

P698

Q37416242-C063D909-D06E-433E-B0A3-2100D85DD8E6

P932

Q37416242-EEA8F774-5153-4CF5-BF9F-8D1BA6471927

P356

1078-0432.CCR-13-0621

P1433

Clinical Cancer Research

P1476

HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s

@en

P2093

David Karnak

http://www.w3.org/2001/XMLSchema#string

Diane M Simeone

http://www.w3.org/2001/XMLSchema#string

James Fuchs

http://www.w3.org/2001/XMLSchema#string

Jiayuh Lin

http://www.w3.org/2001/XMLSchema#string

Liang Xu

http://www.w3.org/2001/XMLSchema#string

Ling Li

http://www.w3.org/2001/XMLSchema#string

Rachel Thompson

http://www.w3.org/2001/XMLSchema#string

Theodore S Lawrence

http://www.w3.org/2001/XMLSchema#string

Wenhua Tang

http://www.w3.org/2001/XMLSchema#string

Xiaojie Meng

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays

STATs in cancer inflammation and immunity: a leading role for STAT3

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells

Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides.

Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells

HAb18G/CD147 cell-cell contacts confer resistance of a HEK293 subpopulation to anoikis in an E-cadherin-dependent manner

A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum.

P304

6703-6715

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-13-0621

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24132924

http://www.w3.org/2001/XMLSchema#string

P932

3873783

http://www.w3.org/2001/XMLSchema#string